Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

RGenix
310 East 67th Street, Suite 1-12Ž
New York, NY 10065
Phone: 646-856-9261
http://www.regenix.com/

Rgenix is a privately-held cancer therapeutics company focused on the discovery and development of novel cancer drugs that target key pathways in cancer progression. Using a miRNA based target discovery platform developed by Rgenix scientific co-founders at The Rockefeller University, the company is developing several first-in-class drug candidates to treat cancers of high unmet need. The company brings together distinguished scientific founders and a leadership team with a seasoned Board comprised of experienced drug developers.

Key Contact
Name
Masoud Tavazoie
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
06/15/16 $33,000,000 Series B Alexandria Real Estate Equities
Conegliano Ventures
Novo A/S
Partnership Fund for New York City
Sofinnova Partners
undisclosed
10/09/18 $40,000,000 Series C Alexandria Venture Investments
Lepu Medical
Novo Holdings
Oceanpine Capital
Partnership Fund for New York City
Sofinnova Partners
WuXi AppTec
undisclosed